Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Contact Dermatitis
|
May 1, 1996
Statistical evaluation of the persistence of acquired hypersensitivity by standardized patch tests
F Ayala, N Balato, G Lembo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response
E Nettis, S M Ferrucci, G Pellacani, et al.
Journal of Investigational Allergology & Clinical Immunology
|
May 8, 2020
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis
E Nettis, M Ortoncelli, G Pellacani, et al.
Journal of Investigational Allergology & Clinical Immunology
|
August 29, 2020
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study
E Nettis, S M Ferrucci, M Ortoncelli, et al.
The British Journal of Dermatology
|
September 30, 2020
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
E Nettis, G Fabbrocini, M Ortoncelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 8, 2024
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study
L Gargiulo, L Ibba, F Piscazzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study
C Patruno, M Napolitano, G Argenziano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
L Stingeni, L Bianchi, E Antonelli, et al.
The Journal of Dermatological Treatment
|
May 22, 2020
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M C Fargnoli, M Esposito, S Ferrucci, et al.
The Journal of Dermatological Treatment
|
October 25, 2019
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M C Fargnoli, M Esposito, S Ferrucci, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Contact Dermatitis
|
May 1, 1996
Statistical evaluation of the persistence of acquired hypersensitivity by standardized patch tests
F Ayala, N Balato, G Lembo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response
E Nettis, S M Ferrucci, G Pellacani, et al.
Journal of Investigational Allergology & Clinical Immunology
|
May 8, 2020
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis
E Nettis, M Ortoncelli, G Pellacani, et al.
Journal of Investigational Allergology & Clinical Immunology
|
August 29, 2020
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study
E Nettis, S M Ferrucci, M Ortoncelli, et al.
The British Journal of Dermatology
|
September 30, 2020
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
E Nettis, G Fabbrocini, M Ortoncelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 8, 2024
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study
L Gargiulo, L Ibba, F Piscazzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study
C Patruno, M Napolitano, G Argenziano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
L Stingeni, L Bianchi, E Antonelli, et al.
The Journal of Dermatological Treatment
|
May 22, 2020
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M C Fargnoli, M Esposito, S Ferrucci, et al.
The Journal of Dermatological Treatment
|
October 25, 2019
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M C Fargnoli, M Esposito, S Ferrucci, et al.
Page
of 6